medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.
Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 15 days
First‑in‑human CRISPR/Cas12a sickle cell therapy treated; gene editing shows promise / 1 month
Favipiravir shows promise in Lassa fever Phase 2 trial / 15 days
FDA approves Rocket Pharma gene therapy for ultra‑rare immune disorder / 2 months
One hepatitis B drug shows early functional cures in trial / 2 days
Global study finds over 250,000 meningitis deaths in 2023 / 2 months
Pediatricians’ immune cells yield antibody cocktail protecting against RSV and hMPV / 3 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.